Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1

Leila Chaouch1, Miniar Kalai11, Imen Darragi1

  • 1a Université de Tunis El Manar, Institut Pasteur de Tunis, Laboratoire d'Hématologie Moléculaire et Cellulaire , Tunis , Tunisie.

Insights

Children with sickle cell anemia (SCA) and specific gene variations in UGT1A1 and SLCO1A2 face a significantly higher risk of developing gallstones. This study highlights key genetic factors contributing to cholelithiasis in pediatric SCA patients.

Area of Science:

  • Genetics
  • Pediatrics
  • Gastroenterology

Background:

  • Hyperbilirubinemia in sickle cell anemia (SCA) can lead to pigment gallstones.
  • Enzyme defects in bilirubin metabolism may exacerbate gallstone formation.
  • Genetic polymorphisms in bilirubin metabolism genes are implicated.

Purpose of the Study:

  • To investigate the correlation between specific gene polymorphisms and gallstone presence in Tunisian pediatric SCA patients.
  • To analyze polymorphisms in SLCO1B1 (rs4149056), SLCO1A2 (rs4149000), and UGT1A1 (rs8175347, rs887829).

Main Methods:

  • Study included 102 Tunisian pediatric SCA patients with hyperbilirubinemia.
  • 52 patients had cholelithiasis; 50 did not.
  • Gene polymorphisms analyzed via PCR/sequencing; frequencies compared using Pearson's chi-square test.

Main Results:

  • Children with a combined genotype (TA7TA7)/TT/TC/GA showed a significantly higher risk of gallstones.
  • This combined genotype was associated with an 18.27-fold increased risk (P=0.0027).

Conclusions:

  • UGT1A1 and SLCO1A2 gene polymorphisms are implicated in the development of gallstones in SCA.
  • Findings highlight the role of specific genetic variations in SCA-related cholelithiasis.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
88
Pedigree Analysis01:35

Pedigree Analysis

Overview
91.1K
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
19.8K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
10.1K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
136